256 related articles for article (PubMed ID: 31418010)
41. A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.
Tassabehji M; Carette M; Wilmot C; Donnai D; Read AP; Metcalfe K
Eur J Hum Genet; 1999; 7(7):737-47. PubMed ID: 10573005
[TBL] [Abstract][Full Text] [Related]
42. Neuropsychological Genotype-Phenotype in Patients with Williams Syndrome with Atypical Deletions: A Systematic Review.
Serrano-Juárez CA; Prieto-Corona B; Rodríguez-Camacho M; Sandoval-Lira L; Villalva-Sánchez ÁF; Yáñez-Téllez MG; López MFR
Neuropsychol Rev; 2023 Dec; 33(4):891-911. PubMed ID: 36520254
[TBL] [Abstract][Full Text] [Related]
43. Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.
Sakurai T; Dorr NP; Takahashi N; McInnes LA; Elder GA; Buxbaum JD
Autism Res; 2011 Feb; 4(1):28-39. PubMed ID: 21328569
[TBL] [Abstract][Full Text] [Related]
44. A mouse single-copy gene, Gtf2i, the homolog of human GTF2I, that is duplicated in the Williams-Beuren syndrome deletion region.
Wang YK; Pérez-Jurado LA; Francke U
Genomics; 1998 Mar; 48(2):163-70. PubMed ID: 9521869
[TBL] [Abstract][Full Text] [Related]
45. Variation in the Williams syndrome GTF2I gene and anxiety proneness interactively affect prefrontal cortical response to aversive stimuli.
Jabbi M; Chen Q; Turner N; Kohn P; White M; Kippenhan JS; Dickinson D; Kolachana B; Mattay V; Weinberger DR; Berman KF
Transl Psychiatry; 2015 Aug; 5(8):e622. PubMed ID: 26285132
[TBL] [Abstract][Full Text] [Related]
46. Williams Syndrome neuroanatomical score associates with GTF2IRD1 in large-scale magnetic resonance imaging cohorts: a proof of concept for multivariate endophenotypes.
Fan CC; Schork AJ; Brown TT; Spencer BE; Akshoomoff N; Chen CH; Kuperman JM; Hagler DJ; Steen VM; Le Hellard S; Håberg AK; Espeseth T; Andreassen OA; Dale AM; Jernigan TL; Halgren E;
Transl Psychiatry; 2018 Jun; 8(1):114. PubMed ID: 29884845
[TBL] [Abstract][Full Text] [Related]
47. A small 7q11.23 microduplication involving GTF2I in a family with intellectual disability.
Pinelli M; Terrone G; Troglio F; Squeo GM; Cappuccio G; Imperati F; Pignataro P; Genesio R; Nitch L; Del Giudice E; Merla G; Testa G; Brunetti-Pierri N
Clin Genet; 2020 Jun; 97(6):940-942. PubMed ID: 32349160
[TBL] [Abstract][Full Text] [Related]
48. Williams syndrome.
Kozel BA; Barak B; Kim CA; Mervis CB; Osborne LR; Porter M; Pober BR
Nat Rev Dis Primers; 2021 Jun; 7(1):42. PubMed ID: 34140529
[TBL] [Abstract][Full Text] [Related]
49. The role of GTF2IRD1 in the auditory pathology of Williams-Beuren Syndrome.
Canales CP; Wong AC; Gunning PW; Housley GD; Hardeman EC; Palmer SJ
Eur J Hum Genet; 2015 Jun; 23(6):774-80. PubMed ID: 25248400
[TBL] [Abstract][Full Text] [Related]
50. A 1.3-mb 7q11.23 atypical deletion identified in a cohort of patients with williams-beuren syndrome.
Delgado LM; Gutierrez M; Augello B; Fusco C; Micale L; Merla G; Pastene EA
Mol Syndromol; 2013 Mar; 4(3):143-7. PubMed ID: 23653586
[TBL] [Abstract][Full Text] [Related]
51. Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models.
Deurloo MHS; Turlova E; Chen WL; Lin YW; Tam E; Tassew NG; Wu M; Huang YC; Crawley JN; Monnier PP; Groffen AJA; Sun HS; Osborne LR; Feng ZP
Mol Neurobiol; 2019 May; 56(5):3313-3325. PubMed ID: 30120731
[TBL] [Abstract][Full Text] [Related]
52. TFII-I, a candidate gene for Williams syndrome cognitive profile: parallels between regional expression in mouse brain and human phenotype.
Danoff SK; Taylor HE; Blackshaw S; Desiderio S
Neuroscience; 2004; 123(4):931-8. PubMed ID: 14751286
[TBL] [Abstract][Full Text] [Related]
53. Integration of a c-myc transgene results in disruption of the mouse Gtf2ird1 gene, the homologue of the human GTF2IRD1 gene hemizygously deleted in Williams-Beuren syndrome.
Durkin ME; Keck-Waggoner CL; Popescu NC; Thorgeirsson SS
Genomics; 2001 Apr; 73(1):20-7. PubMed ID: 11352562
[TBL] [Abstract][Full Text] [Related]
54. New TFII-I family target genes involved in embryonic development.
Makeyev AV; Bayarsaihan D
Biochem Biophys Res Commun; 2009 Sep; 386(4):554-8. PubMed ID: 19527686
[TBL] [Abstract][Full Text] [Related]
55. An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter.
Huo Y; Su T; Cai Q; Macara IG
Cell Rep; 2016 Jun; 15(10):2089-2096. PubMed ID: 27239038
[TBL] [Abstract][Full Text] [Related]
56. An Exploration of Social Cognition in Children with Different Degrees of Genetic Deletion in Williams Syndrome.
Serrano-Juárez CA; Prieto-Corona B; Rodríguez-Camacho M; Venegas-Vega CA; Yáñez-Téllez MG; Silva-Pereyra J; Salgado-Ceballos H; Arias-Trejo N; De León Miranda MA
J Autism Dev Disord; 2021 May; 51(5):1695-1704. PubMed ID: 32812194
[TBL] [Abstract][Full Text] [Related]
57. Global analysis of gene expression in the developing brain of Gtf2ird1 knockout mice.
O'Leary J; Osborne LR
PLoS One; 2011; 6(8):e23868. PubMed ID: 21909369
[TBL] [Abstract][Full Text] [Related]
58. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice.
Young EJ; Lipina T; Tam E; Mandel A; Clapcote SJ; Bechard AR; Chambers J; Mount HT; Fletcher PJ; Roder JC; Osborne LR
Genes Brain Behav; 2008 Mar; 7(2):224-34. PubMed ID: 17680805
[TBL] [Abstract][Full Text] [Related]
59. TFII-I and AP2α Co-Occupy the Promoters of Key Regulatory Genes Associated with Craniofacial Development.
Miranda P; Enkhmandakh B; Bayarsaihan D
Cleft Palate Craniofac J; 2018 Jul; 55(6):865-870. PubMed ID: 28085512
[TBL] [Abstract][Full Text] [Related]
60. Identification of the TFII-I family target genes in the vertebrate genome.
Chimge NO; Makeyev AV; Ruddle FH; Bayarsaihan D
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9006-10. PubMed ID: 18579769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
